LD-2 disclosure · 1st Quarter - Report
PFIZER
Client
- Name
- PFIZER
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
6 issuesHealth Issues
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
LobbyistsSUSAN HIRSCHMANN · ms MELINDA M MAXFIELD · mr MATTHEW B HOEKSTRA · CHRISTOPHER E. WILCOX · JEANNE HAGGERTY · ROBERT BUTORA
Covered position (CHRISTOPHER E. WILCOX): LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
Covered position (ROBERT BUTORA): Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP.
LobbyistsSUSAN HIRSCHMANN · mr CHRISTOPHER W HATCHER · mr MATTHEW B HOEKSTRA · CHRISTOPHER E. WILCOX · JEANNE HAGGERTY · mr JOSHUA DAVID FENDRICK